In our work, we analyzed the role of the CD100/CD72 and PD-1/PD-L1 axes in immune response dysfunction in human immunodeficiency virus (HIV)-1 infection in which high expressions of PD-1 and PD-L1 were associated with an immunosuppressive state via limitation of the HIV-1-specific T-cell responses. CD100 was demonstrated to play a relevant role in immune responses in various pathological processes and may be responsible for immune dysregulation during HIV-1 infection. We investigated the function of CD72/CD100, and PD
Introduction
Dysregulation of HIV-specific T and B-cell responses is the principal cause for the lack of control of HIV replication. Chronic infection with the persistent presence of viral antigens gives rise to B-and T-cell exhaustion, which is characterized by loss of proliferative capacity and effector functions [1, 2] . Negative regulatory pathways (such as the PD-1/PD-L1 axis) under a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 physiological conditions play an important role in maintaining peripheral tolerance and preventing excessive immune activation [3, 4] . Nonetheless, excessive activation of negative regulatory pathways induces immune exhaustion in part via the PD-1/PD-L1 axis. The PD-1/ PD-L1 axis was identified as the major regulator of T-cell exhaustion during chronic HIV/SIV infection and appears to be responsible for the dysfunction of HIV-specific CD8 + T cells [5] [6] [7] [8] [9] [10] . Increased PD-1 was also associated with T-cell exhaustion in HIV/Mycobacterium tuberculosis co-infection and was associated with senescence and activation markers on mucosalassociated invariant T cells during HIV and hepatitis C virus (HCV) infection [11] [12] [13] . PD-1 expression is induced on CD4 + , natural killer (NK) T-cell subsets, B cells, monocytic cells, and most notably on the surface of CD8 + T cells upon activation during HIV-1 infection [7, 13, 14] . PD-L1 is constitutively expressed on B cells, dendritic cells (DCs), macrophages and T cells, and it is also upregulated upon activation [15] . The PD-L1 expression levels on DCs and monocytes positively correlate with viral load (VL) in HIV-1 + individuals [16] . The PD-L1 expression was also observed at the surface of T cells in HIV-1 + individuals, and blockade of PD-L1 was shown to induce higher proliferation of specific anti-Gag T cells [17] . Altogether, these data suggest that the PD-1/PD-L1 pathway plays an important role in exhaustion of antiviral CD8 + T cells during chronic HIV-1 infection. Nonetheless, little is known about B-cell dysregulation since B cells may bear PD-1 and PD-L1 markers on their surfaces. However, PD-1 induces negative regulation of B-cells activation [18] . Therefore, PD-1 and PD-L1 could have an antagonist role.
In HIV-1 infection, immune cell dysregulation is multifactorial, and recent publications indicate that CD72/CD100 may play a relevant role in immune regulation [19] [20] [21] . It was demonstrated that CD100, which is constitutively expressed on T cells, and CD72 expression could be upregulated on the surface of T cells upon activation [22] . CD72 is essentially expressed at the surface of antigen presenting cells (such as B cells), but it was also observed at the surface of Treg cells in which CD72 is involved in Foxp3 +
CD4
+ Treg cells expansion [23] .
CD72 on B cells induces dual effects that can be explained by its association with positive and negative signaling molecules [24, 25] . Indeed, it was observed that CD72 has not only been implicated in naïve B-cell differentiation suppression and reduced survival of mature B cells but also participates in IL-10 production by regulatory B cells [23] . More recently, it was described that CD72/CD100 interaction was also required for T-cell proliferation and that CD100 up-regulation at the surface of B cells was associated with B-cell activation and differentiation [22, 26] . CD100-associated signaling rescues B cells from apoptosis and causes B-cell proliferation and survival [27] [28] [29] . In the context of HIV infection, it was observed that a decrease in CD100 expression at the surface of CD8 + T cells was linked to reduced effector functions that render T cells incapable of optimally responding to pathogens [19] . Also, in the context of HCV infection, it was observed that CD8 + T cells expressing CD100 were able to induce the production of interferon alpha (IFNα) through the CD72/CD100 axis [30] . Thus, the CD72/CD100 axis appears to have an important role in the T-and B-cell functions. However, it is still unclear what role the CD72/CD100 axis has during normal immune responses and HIV-1 infections.
We showed a general dysregulation in which CD100-expressing CD4 + T cells correlated with exhaustion markers such as PD-1 on CD4 + and CD8 + T cells and the negative regulatory marker PD-L1 on CD4 + and CD8 + T cells in HIV-infected treatment-naïve individuals. These correlations could be associated with a possible attempt by the immune system to limit T-cell activation and proliferation. PD-L1-expressing B-cell frequencies were associated with the frequencies of CD72-expressing CD4 + and CD8 + T cells in healthy individuals that were lost in HIV-1 + individuals and, could be related to the loss of the suppressive ability over the activated T cells in viremic patients. Moreover, a clear correlation between the intensity of CD72 expression at the surface of CD8 + T cells and the ability of T cells to express IFN-γ was observed. Altogether, these outcomes indicate a link between the regulatory markers on T and B cells, thereby confirming the role of HIV-1 infection in dysregulating immune system homeostasis. Interestingly, little is known about the relationships between CD72/CD100 and PD-1/PD-L1 axes in the context of HIV-1 infection. The relation between T and B cells is multifactorial, and it is believed that this may have important implications for disease progression. Therefore, the study of cell surface marker dysregulation that is involved in negative and positive signaling of the immune response is crucial to better understanding of HIV-1 infection pathogenesis.
Materials and methods

Participants
All individuals were recruited under a protocol accepted by the Clinical Ethics Committee of the Ramón y Cajal Hospital (reference number: RyC-419-14) and the Gregorio Marañón Hospital (reference number: HGUGM-04/2014) according to the principles described in the Declaration of Helsinki (2013). Data analyses were based on anonymized routine clinical data. Written informed consent for study participation was obtained from all individuals. The research was conducted between December 2014 and December 2016. All samples were processed within one hour after sample reception on the day of blood extraction. We studied three groups of individuals: i) HIV-infected treatment naïve individuals that were newly diagnosed. Peripheral blood samples were collected before they received antiretroviral treatment and presented with detectable viral loads (VL) in plasma (group VL; superior to 50 copies/ml of plasma); ii) treated-HIV-1 + individuals who received antiretroviral treatment and presented with undetectable VL in plasma (group uVL; inferior to 50 copies/ml of plasma); and iii) healthy individuals who were not infected by HIV-1 used as the control group (Table 1) . Positivity diagnosis for HIV-1 was done by the use of enhanced ELISA assays that detected both HIV antibodies and antigens (fourth generation assay) and permits earlier detection of HIV seroconversion followed by western blot confirmation.
Direct labeling of whole blood and intracellular staining
Whole blood was surface labeled, lysed, and analyzed by flow cytometry (S1 Table presents the list of antibodies used in this study and S1-S3 Figs). For intracellular cytokine labeling, 1×10 6 of freshly isolated peripheral blood mononuclear cells (PBMCs) were cultured for 5 h with phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich; 10ng/ml) and ionomycin (SigmaAldrich; 0.25μg/mL) at 37˚C, 5% CO 2 ; GolgiStop was added after the first 1 h of culture. Cells were then surface labeled, washed, intracellularly labeled using the Fixation/Permeabilization Solution Kit (BD Biosciences), and then analyzed by flow cytometry using a Gallios cytometer (Beckman Coulter). Data were analyzed using Kaluza Analysis software (Beckman Coulter 
Results
Description of the individuals followed in this study
We evaluated 39 individuals divided into three groups: (i) Thirteen VL individuals, HIV + individuals that did not receive antiretroviral treatment and presented with detectable VL in 
Expression of PD-1 and PD-L1 markers on T and B cells
During HIV-1 infection, weak antiviral immune responses lead to chronic infections that in turn induce the activation of negative regulatory pathways, such as the PD-1/PDL-1 axis. Therefore, we analyzed PD-1 and PD-L1 marker expression on several cellular subsets such as CD8 + and CD4 + T cells and on CD19 + cells (B cells). Both markers were highly expressed on T and B cells ( Fig 1A and S2 Fig) . Thus, we followed PD-1 hi and PD-L1 hi expressions along with the expression intensities at the surface of T and B cells from HIV + and healthy individuals (Fig 1A) . The frequencies of PD-1 hi and PD-L1 hi (Fig 1B) had significantly increased in CD4 + and CD8 + T cells and CD19 + B cells as the mean fluorescent intensities (MFI) of PD-1 and PD-L1 expressions on the three cellular compartments (Fig 1C) . The effective treatment in uVL-HIV + individuals reduced the MFI to the levels observed in healthy individuals. Therefore, we confirmed that PD-1 and PD-L1 were over-expressed at the surface of T and B cells during HIV-1 replication.
Since the union between PD-1 and its ligand, PD-L1, is pivotal to blocking cell activation, we analyzed the relationships between both markers. No correlation was observed between CD19 
CD72/CD100 expression on T and B-cell surface
The CD72 marker, which is a negative regulator of B cell responsiveness by preventing the differentiation of naïve B cells to plasmablasts, and has been poorly studied in the HIV-1 context, was analyzed ( S3 Fig). CD72 is the receptor for the class IV semaphorin (CD100) that is also highly expressed at the surface of B cells (Fig 3A) and at the surface of T cells (data not shown). No significant changes were observed in the frequencies and in the MFI of CD100 at the surfaces of CD4 + and CD8 + T cells (data not shown). On the contrary, CD72 and CD100 hi expression levels were increased at the surface of B cells in HIV-1 + individuals (Fig 3A and 3B ) even if frequencies of CD72 + B cells did not present significant changes (Fig 3B) . In addition, we observed an increase in CD72 frequencies and MFI at the surface of CD4 + and CD8 + T cells (Fig 3C) in VL-HIV-1 + individuals. It was interesting to note that CD72 MFI at the CD4 + and CD8 + T cell surfaces were identical in the two groups of analyzed HIV-1 + individuals (Fig 3C) ,
showing that effective treatment did not reverse the increase in CD72 MFI. In conclusion, we observed an increase in CD100 expression at the surface of B cells and a parallel increase in the expression of its receptor, CD72, on B and T cells from HIV-1 + individuals.
CD100 frequency is associated with PD-1 and PD-L1 expression on T cells
As there was a general increase in PD-1, PD-L1, CD72 and CD100 expressions at the surface of T and B cells, we analyzed whether any of these markers were specifically correlated. No   Fig 1. PD-1 relationships were observed between CD100 hi expressed at the surface of CD4 + T cells and PD-1 hi at the surface of CD4 + and CD8 + T cells in healthy individuals (Fig 4A) . However, positive and significant correlations were observed in VL-HIV-1 + individuals (Fig 4A) . Such positive correlations were also observed between CD100 hi levels on CD4 + T and CD8 + T cells and PD-L1 hi expressed on CD4 + and CD8 + T cells (Fig 4B and 4C) but not in healthy individuals.
Therefore, during HIV-1 replication, CD100 expression was related to the PD-1/PD-L1 axis.
On the other hand, we observed that CD100 expression levels were also increased at the surface of CD19 + cells (Fig 3B) . Thus, we studied the relationship between CD19 + CD100 hi and the PD-1/PD-L1 axis. We observed that CD19 + CD100 hi was positively and significantly correlated with PD-1 expression at CD4 + and CD8 + T cell surfaces in healthy individuals (Fig 5A) Fig   5B) . Therefore, the increase in the activation signal CD100 at the surface of B cells was associated with the PD-L1 marker that appears to be related to viral escape during HIV-1 infection.
On the other hand, CD72 expressed on CD4 + and CD8 + T cells was significantly and negatively correlated with PD-L1 at B cell surfaces in healthy individuals (Fig 6A) . This finding confirmed a link between both suppressive markers CD72 and PD-L1 and indicated that CD72/ CD100 and PD-1/PD-L1 axes have a role in immune homeostasis. Nevertheless, during HIV-1 + infection, these relationships were in part lost.
Because CD100 expression on CD8 + T cells was observed to be related to IFN-γ production (Fig 6B and data not shown) . Similarly, a positive correlation was observed between the MFI of the PD-1 hi expression on CD4 + T cells and IFN-γ-producing T cells (Fig 6C) . Therefore, not only imbalances associated with the upregulation of studied markers in T and B cells during HIV-1 + infection, but also the dysregulation of relationship between the costimulatory markers CD72 and PD-1 and the production of a pro-inflammatory cytokine on T cells were observed, which may be a very important part of the dysregulation of immune system homeostasis and hyper-activation.
Discussion
In this study, we report that treatment-naïve HIV-1 infected individuals present with an increase in PD-1/PD-L1 and CD72/CD100 axis markers when compared to patients on antiretroviral therapy or healthy controls (summarized in Fig 7) . Efficient antiretroviral treatment permitted a reversion of such high expression, except for the levels of CD72 expression at CD4 + and CD8 + T cell surfaces. This finding indicated that a replicative virus was generally needed to induce up-regulation of these markers. CD72 was already observed to be increased after cell activation [22] . Thus, sustained CD72 expression at CD4 + and CD8 + T cell surfaces might be linked to the maintenance of general activation of the immune system observed in HIV + individuals. This deduction was supported by the association observed between CD72 expression levels and the frequency of IFNγ-producing T cells. Therefore, we hypothesized that CD72/CD100 may be another exhaustion marker presented by the immune system. One of the markers of the immune dysfunction is a blunted T cell signaling response in HIV + progressors, which was predominantly related to a high basal intracellular phosphorylation level [31] . General phosphorylation is associated with cellular activation, but on other hand constant phosphorylation of CD72 negatively regulates B-cell receptor (BCR) signaling on B cells [32] , and phosphorylation of PD-1 might inhibit T-cell receptor (TCR) and BCR signaling on T and B cells, respectively [33] . On other hand, CD72 on T cells is an activation marker [22] , and its phosphorylation might maintain a TCR-related activation state. This sustained phosphorylation level in immune cells might be pivotal in understanding hyper-activation and therefore in understanding immune system exhaustion. More interestingly, a relationship between CD100 + (a marker related to B-cell activation [28, 29] CD72/CD100 and PD-1/PD-L1 axes in HIV-1 + individuals observed (Fig 7) . Such positive correlations were not detected in healthy individuals. The association between proliferating B cells and suppressive CD4/CD8 T cells provides an indication of a dysregulated HIV-specific response. Also, this dysregulation may be observed with the loss of the positive correlation between CD19 + CD100 hi and the exhaustion marker PD-1 expression at the surface of CD4 + and CD8 + T cells in VL-HIV-1 + individuals (Fig 7) . This loss of correlation permitted us to confirm that the immune system was not able to control the balance between cellular proliferation and activation/exhaustion. In parallel, a negative correlation between CD19 + PD-L1 + and CD72-expressing CD4 + and CD8 + T cells in healthy individuals was observed and may be related to finely tuned control of activation and proliferation status in healthy individuals but not in VL-HIV-1 + individuals. Indeed, CD72/ CD100 axis on T-cell subsets is associated with T cell activation and proliferation. In addition, CD72 has been shown to be involved in the expansion of the regulatory T cells [22, 23] . We assume that the contact between CD19 + PD-L1 + and activated T cells may limit inflammation in the normal immune system in healthy individuals, which can be lost during HIV-1 infection. Very little is known about the role of CD72 at the B and T cell surface, but its union with CD100 has been shown to be associated with the activation of the immune regulation [24, 30] . Loss of suppression of the immune system may induce hyper-activation leading further to cellular exhaustion. Our results seem to confirm this hypothesis since the CD100 increases at CD4 + and CD8 + T cell surfaces were associated with PD-1 and PD-L1 expression increases CD4 + and CD8 + T cell surfaces. This data indicates that the CD100, an activation marker, is associated with markers of T cell suppression, namely PD-1 and PD-L1. It has already been showed that CD100 is important for antigen-specific responses since HIV-1-specific IFN-γ production is associated with the absolute number of CD100 + CD8 + T cells [19, 30] and that PD-1 is associated with immune dysfunction [6, 7] . During HCV infection, the increase in CD100 at the surface of naïve CD8 + T cells interacting with the CD72 receptor was related to an enhanced PBMC capability to secrete IFN-γ and TNF-α [30] . In our study, we showed a correlation between the level of CD72 expression on CD8 + T cells and the frequency of IFN-γ-producing T cells. Therefore, it seems that CD72 on B cells may have a suppressive function CD72/CD100 and PD-1/PD-L1 axes in HIV-1 + individuals but may be linked to a pro-inflammatory response when expressed on T cells [34] [35] [36] . We have previously demonstrated that HIV-1 could direct B cells to an IL-10-producing phenotype, which could as a consequence, contribute to immune system dysregulation [37] . These data, together with findings from this study, highlight the potential dual functionality of the CD72/CD100 axis to first maximize immune system activation and second to mediate immune suppression via IL-10 production. Additional investigations will be required to confirm such hypothesis in the context of HIV-1 infection.
On the other hand, it has previously been reported that expansion of CD8 + T cells lacking CD100 was observed in HIV-1 infection [19] although an increase in CD8 + -expressing CD100 was demonstrated in our work. However, one conclusion matches Eriksson's work, in which it was demonstrated that CD100 expression on T cells seems to be associated with HIV-1 disease progression. It would be interesting to examine such opposite results in future since the CD100/CD72 axis might be very important for immune activation regulation. In our work, we observed that CD8 It was described that activation of T cells could lead to the cleavage of CD100, which permitted the increase of soluble CD100 in plasma [38] and was positively correlated with disease severity or progression in various pathologies [39] [40] [41] . However, it has been shown that soluble CD100 in plasma had decreased in HIV-1 + individuals [42] , and we demonstrated that CD100 expression was increased at the surface of B cells and did not change at T cell surface. Therefore, we hypothesized a lack of cleavage of the CD100 protein, and as a consequence, could lead to a sustained or higher presence of CD100 at T and B cell surfaces. Moreover, the presence of high CD100 levels at the cell surface could be associated with improved interactions with CD72-bearing cells, which could lead to an increase in intracellular phosphorylation and B-cell dysregulation [43, 44] . Immune system dysfunction during HIV-1 infection is undoubtedly multifactorial, but accumulating evidence indicates that CD100 and CD72 may play an important role in immune dysregulation of effector cell functions [19] [20] [21] . It would be interesting to contrast CD100 and CD72 expression markers with the others negative checkpoint regulators (NCR) such as LAG-3, TIM-3, 2B4, or CTLA-4 on T cells, NK, and DC [10] . Indeed, it was demonstrated that PD-1 and PD-L1 are both members of the NCR family; cells expressing these both markers (on NK or T cells) and able to express also LAG-3 and TIM3 were even more exhausted than cells expressing only PD-1 [45] . Moreover, it was demonstrated that invariant NK T cells, which are important immunoregulatory cells that can influence other immune cells, can express high 2B4 levels during HIV infection and that high 2B4 expression is correlated with HIV disease progression [46] . Therefore, it will be highly interesting to analyze CD72/CD100 and PD-1/PD-L1 expressions in the context of other NCR expression in order to obtain a general vision of cellular exhaustion during HIV infection.
Future studies with larger samples sizes and more female patients might confirm these hypotheses. Indeed, the modest samples size it is one of the limitations of our study and in addition the population studied was predominantly male (>75%) so generalizability to female should be also applied cautiously.
To our knowledge, no group has demonstrated that CD100 and CD72 and the PD-1/PD-L1 axis were associated during HIV-1 infection. We hypothesized that there are two indications that may be associated with upregulation of the expression of all these markers and may limit adequate immune system responses thus leading it to hyper-activation and exhaustion. One indication suggests that the PD-1/PD-L1 interaction may exert inhibitory effects that limit effector cells responses. The second indication is based on the observed increase in CD72/ CD100, which might maximize the T-and B-cells activation and suggests that it might also be involved in limiting immune system response. Based on the data reported in this study, it is suggested that further studies should be performed to investigate the role of the CD72/CD100 axis upon T-and B-cell exhaustion. 
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